FallberichtOpen Access
CDK4/6 Inhibitor-Mediated Cutaneous Toxicity in Breast Cancer
Cureus · 25.03.2026
DOI: 10.7759/cureus.105839 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cureus, erschienen am 25.03.2026. Verfasst von Juan M Alcantar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Hematology and Medical Oncology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, USA. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
breast cancerbullous dermatitiscdk4/6 inhibitorsrashtopical corticosteroids
Autor:innen und Institutionen
- Hematology and Medical Oncology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, USA.
- Medicine, University of California Los Angeles David Geffen School of Medicine, Los Angeles, USA.
Zitieren
APA
Alcantar, J. M., Chuang, F. L., & Kim, D. D. (2026). CDK4/6 Inhibitor-Mediated Cutaneous Toxicity in Breast Cancer. Cureus. https://doi.org/10.7759/cureus.105839
Vancouver
Alcantar JM, Chuang FL, Kim DD. CDK4/6 Inhibitor-Mediated Cutaneous Toxicity in Breast Cancer. Cureus. 2026. doi:10.7759/cureus.105839
BibTeX
@article{Alcantar2026,
author = {Alcantar, Juan M and Chuang, Fukai L and Kim, David D},
title = {CDK4/6 Inhibitor-Mediated Cutaneous Toxicity in Breast Cancer},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.105839}
}
EUVIMED